In vitro activity of daptomycin against methicillin- and multi-resistant Staphylococcus haemolyticus invasive isolates carrying different mec complexes

Diagnostic Microbiology and Infectious Disease

Volumn 61, Issue 2, 2008, Pages 227-231

  Campanile, Floriana ^a,b   Bongiorno, Dafne ^a,b   Borbone, Sonia ^a,b   Falcone, Marco ^a,b   Giannella, Maddalena ^a,b   Venditti, Mario ^a,b   Stefani, Stefania ^a,b  

^a UNIVERSITY OF CATANIA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Daptomycin; MRSH invasive isolates

Indexed keywords

CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; LINEZOLID; MEROPENEM; METICILLIN; RIFAMPICIN; TEICOPLANIN; TETRACYCLINE; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; PHENOTYPE; PRIORITY JOURNAL; STAPHYLOCOCCUS HAEMOLYTICUS;

ANTI-BACTERIAL AGENTS; DAPTOMYCIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS HAEMOLYTICUS;

EID: 43549096156     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2008.01.019     Document Type: Article

References (32)

1. Baba T., Takeuchi F., and Kuroda M. The Staphylococcus aureus genome. In: Aladeen D., and Hiramatsu K. (Eds). Staphylococcus aureus-molecular and clinical aspects (2004), Harwood Publishing Limited, Chichester, United Kingdom 66-153
2. Biavasco F., Vignaroli C., Lazzarini R., and Varaldo P.E. Glycopeptide susceptibility profiles of Staphylococcus haemolyticus bloodstream isolates. Antimicrob. Agents Chemother. 44 Supp 11 (2000) 3122-3126
3. Billot-Klein D., Gutmann L., Byant D., Bell D., Van Heijenoort J., Grewal J., and Shlaes D.M. Peptidoglycan synthesis and structure in Staphylococcus haemolyticus expressing increasing levels of resistance to glycopeptide antibiotics. J. Bacteriol. 178 (1996) 4696-4703
4. Campanile F., Venditti M., Borbone S., Bongiorno D., Penni A., and Stefani S. Daptomycin activity against multi-resistant Staphylococcus haemolyticus bloodstream isolates from severe infections. 16th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) (2006) 131 [abs. P-1585]
5. Clinical and Laboratory Standard Institute (CLSI). Performance Standard for Antimicrobial Susceptibility Testing: Fifteenth Informational Supplement M100-S16 (2006), CLSI, Wayne, PA
6. Cui L., Tominaga E., Neoh H.M., and Hiramatsu K. Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus. Antimicrob. Agents Chemother. 50 (2006) 1079-1082
7. European Committee on Antimicrobial Susceptibility Testing (EUCAST) (May 2007, date last accessed) Technical notes on antimicrobial susceptibility testing http://www.escmid.org.
8. Falcone M., Campanile F., Giannella M., Borbone S., Stefani S., and Venditti M. Staphylococcus haemolyticus endocarditis: clinical and microbiological analysis of four cases. Diagn. Microbiol. Infect. Dis. 57 (2007) 325-331
9. Falcone M., Micozzi A., Pompeo M.E., Baiocchi P., Fabi F., Penni A., Martino P., and Venditti M. Methicillin-resistant staphylococcal bacteremia in patients with hematologic malignancies: clinical and microbiological retrospective comparative analysis of S. haemolyticus, S. epidermidis and S. aureus. J. Chemother. 16 (2004) 540-548
10. Fowler Jr. V.G., Boucher H.W., Corey G.R., Abrutyn E., Karchmer A.W., Rupp M.E., Levine D.P., Chambers H.F., Tally F.P., Vigliani G.A., Cabell C.H., Link A.S., DeMeyer I., Filler S.G., Zervos M., Cook P., Parsonnet J., Bernstein J.M., Price C.S., Forrest G.N., Fatkenheuer G., Gareca M., Rehm S.J., Brodt H.R., Tice A., and Cosgrove S.E. S. aureus Endocarditis and Bacteremia Study Group. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N. Engl. J. Med. 355 (2006) 653-665
11. Hiramatsu K., Aritaka N., Hanaki H., Kawasaki S., Hosoda Y., Hori S., Fukuchi Y., and Kobayashi I. Dissemination in Japanese hospitals of Staphylococcus aureus strains heterogeneously resistant to vancomycin. Lancet 350 (1997) 1670-1673
12. Huang C.R., Lu C.H., Wu J.J., Chang H.W., Chien C.C., Lei C.B., and Chang W.N. Coagulase-negative staphylococcal meningitis in adults: clinical characteristics and therapeutic outcomes. Infection 33 (2005) 56-60
13. Katayama Y., Ito T., and Hiramatsu K. Genetic organization of the chromosome region surrounding mecA in clinical staphylococcal strains: role of IS431-mediated mecI deletion in expression of resistance in mecA-carrying, low-level methicillin-resistant Staphylococcus haemolyticus. Antimicrob. Agents Chemother. 45 (2001) 1955-1963
14. Low D.E., McGeer A., and Pon R. Activities of daptomycin and teicoplanin against Staphylococcus haemolyticus and Staphylococcus epidermidis, including evaluation of susceptibility testing recommendations. Antimicrob. Agents Chemother. 33 (1989) 585-588
15. Mato R., Campanile F., Stefani S., Crisostomo M.I., Santagati M., Sanches S.I., and de Lencastre H. Clonal types and multidrug resistance patterns of methicillin-resistant Staphylococcus aureus (MRSA) recovered in Italy during the 1990s. Microb. Drug Resist. 10 (2004) 106-113
16. Moise-Broder P.A., Sakoulas G., Forrest A., and Schentag J.J. Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia. Antimicrob. Agents Chemother. 51 (2007) 2582-2586
17. NNIS System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003. Am. J. Infect. Control 31 (2003) 481-498
18. Pitcher D.G., Sanders N.A., and Owen R.J. Rapid extraction of bacterial genomic DNA with guanidium thiocyanate. Lett. Appl. Microbiol. 8 (1989) 151-156
19. Raponi G., Ghezzi M.C., Gherardi G., Dicuonzo G., Caputo D., Venditti M., Rocco M., Micozzi A., and Mancini C. Antimicrobial susceptibility, biochemical and genetic profiles of Staphylococcus haemolyticus strains isolated from the bloodstream of patients hospitalized in critical care units. J. Chemother. 17 (2005) 264-269
20. Reinert R.R., von Eiff C., Kresken M., Brauers J., Hafner D., Al-Lahham A., Schorn H., Lutticken R., and Peters G. Multicenter Study on Antibiotic Resistance in Staphylococci and other Gram-positive Cocci (MARS) Study Group. Nationwide German multicenter study on the prevalence of antibiotic resistance in streptococcal blood isolates from neutropenic patients and comparative in vitro activities of quinupristin-dalfopristin and eight other antimicrobials. J. Clin. Microbiol. 39 (2001) 1928-1931
21. Sader H.S., Fritsche T.R., and Jones R.N. Daptomycin bactericidal activity and correlation between disk and broth microdilution method results in testing of Staphylococcus aureus strains with decreased susceptibility to vancomycin. Antimicrob. Agents Chemother. 50 (2006) 2330-2336
22. Sader H.S., Streit J.M., Fritsche T.R., and Jones R.N. Antimicrobial susceptibility of gram-positive bacteria isolated from European medical centres: results of the Daptomycin Surveillance Programme (2002-2004). Clin. Microbiol. Infect. 12 (2006) 844-852
23. Sader H.S., Streit J.M., Fritsche T.R., and Jones R.N. Antimicrobial activity of daptomycin against multidrug-resistant Gram-positive strains collected worldwide. Diagn. Microbiol. Infect. Dis. 50 (2004) 201-204
24. Sakoulas G., Moise-Broder P.A., Schentag J., Forrest A., Moellering Jr. R.C., and Eliopoulos G.M. Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J. Clin. Microbiol. 42 (2004) 2398-2402
25. Santos Sanches I., Mato R., de Lencastre H., and Tomasz A. CEM/NET Collaborators and the International Collaborators. Patterns of multidrug resistance among methicillin-resistant hospital isolates of coagulase-positive and coagulase-negative staphylococci collected in the international multicenter study RESIST in 1997 and 1998. Microb. Drug Resist. 6 (2000) 199-211
26. Schreckenberger P.C., Ilendo E., and Ristow K.L. Incidence of constitutive and inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci in a community and a tertiary care hospital. J. Clin. Microbiol. 42 (2004) 2777-2779
27. Shittu A., Lin J., Morrison D., and Kolawole D. Isolation and molecular characterization of multiresistant Staphylococcus sciuri and Staphylococcus haemolyticus associated with skin and soft-tissue infections. J. Med. Microbiol. 53 (2004) 51-55
28. Skow A., Mangold K.A., Tajuddin M., Huntington A., Fritz B., Thomson Jr. R.B., and Kaul K.L. Species-level identification of staphylococcal isolates by real-time PCR and melt curve analysis. J. Clin. Microbiol. 43 (2005) 2876-2880
29. Takeuchi F., Watanabe S., Baba T., Yuzawa H., Ito T., Morimoto Y., Kuroda M., Cui L., Takahashi M., Ankai A., Baba S., Fukui S., Lee J.C., and Hiramatsu K. Whole-genome sequencing of Staphylococcus haemolyticus uncovers the extreme plasticity of its genome and the evolution of human-colonizing Staphylococcal species. J. Bacteriol. 187 (2005) 7292-7308
30. Tenover F.C., Arbeit R.D., Goering R.V., Mihelsen P.A., Murray B.E., Persing D.H., and Swaminathan B. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33 (1995) 2233-2239
31. Trakulsomboon S., Danchaivijitr S., Rongrungruang Y., Dhiraputra C., Susaemgrat W., Ito T., and Hiramatsu K. First report of methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Thailand. J. Clin. Microbiol. 39 (2001) 591-595
32. von Eiff C., Reinert R.R., Kresken M., Brauers J., Hafner D., and Peters G. Nationwide German multicenter study on prevalence of antibiotic resistance in staphylococcal bloodstream isolates and comparative in vitro activities of quinupristin-dalfopristin. J. Clin. Microbiol. 38 (2000) 2819-2823